Physician

Robert Steven Wolff, M.D.

According to 2025 Medicare claims, Robert Wolff, M.D. (NPI: 1477558195) practices ophthalmology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF NEVADA LLP (NPI: 1053359489; TIN: 260076062) and primary practice location at 89703-8462.

Wolff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,384 traditional Medicare patients, billed 6,397 HCPCS/CPT codes, and received $692,771 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 973 prescription claims across 508 beneficiaries totaling $158,292 in drug costs, led by Prolensa (Bromfenac Sodium). 2021 DME data shows 11 claims. Open Payments data shows 21 records totaling $1,594. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,135,588 to $692,771. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $187,266 and ending at $158,292. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,754	9,808	$1,135,588
2016	1,643	9,410	$1,069,095
2017	1,487	9,015	$968,888
2018	1,750	10,085	$1,085,426
2019	1,790	10,288	$1,126,988
2020	1,804	8,624	$917,431
2021	1,781	9,453	$1,009,817
2022	1,502	7,515	$806,541
2023	1,291	5,696	$646,186
2024	1,384	6,397	$692,771

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	615	2,373	$187,266
2016	765	2,062	$154,517
2017	436	1,331	$86,619
2018	405	1,138	$100,779
2019	340	858	$89,131
2020	405	1,063	$115,371
2021	461	1,187	$134,393
2022	484	1,158	$139,936
2023	601	1,270	$431,647
2024	508	973	$158,292

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	84	84	$4,770
2016	61	61	$3,818
2017	26	26	$1,654
2018	22	22	$1,259
2019	47	47	$2,944
2020	43	43	$2,582
2021	11	11	$559
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	584	970	$360
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	613	613	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	344	384	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	291	391	$63
92136	Measurement of corneal curvature and depth of eye	716	2,086	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolensa	Bromfenac Sodium	304	9,739	$105,946
Restasis	Cyclosporine	12	600	$9,499
Prednisolone Acetate	Prednisolone Acetate	127	4,457	$6,114
Bromfenac Sodium	Bromfenac Sodium	14	499	$3,132
Latanoprost	Latanoprost	229	14,549	$3,117

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$1,594	NEW WORLD MEDICAL,INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Steven Wolff, M.D.?

Tedicare shows public-source Medicare data for Robert Steven Wolff, M.D. (NPI 1477558195), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Steven Wolff, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Steven Wolff, M.D.?

Robert Steven Wolff, M.D. is linked to RETINA CONSULTANTS OF NEVADA LLP (billing NPI 1053359489) in the available physician profile data.

Does Robert Steven Wolff, M.D. have Open Payments data?

Robert Steven Wolff, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.